Background CD4 testing is the recognized gold standard used to stage HIV/AIDS, guide
treatment decisions for HIV-infected persons and evaluate effectiveness of therapy. The …

Background Anaemia has been reported to be one of the more common haematological
disorders affecting people living with HIV (PLHIV)[1-3]. Studies have shown that the …

Accepted: Jan 4, 2011; Published: Jan 15, 2011 Abstract: Background: Hematological
manifestations are common throughout the course of HIV infection. Impact of anemia is the …

Background. In view of the lack of evidence on the possibility of an economically viable,
easy, and readily available biomarker to substitute the traditional role of CD4 counts in HIV …

Background: Renal involvement in HIV patients is relatively common and quite broad.
However, despite an increasingly large number of HIV patients in Asia, systematic studies of …

Background The high cost of CD4 count estimation in resource-limited countries is a major
challenge in initiating patients on highly active antiretroviral therapy (HAART). Therefore …

The expensive and technology limited setting of CD4 count testing is a major setback to the
initiation of HAART in a resource limited country like Nigeria. Simple and inexpensive tools …

Introduction Past endeavours to deal with the obstacle of expensive Cluster of Difference 4
(CD4+) count diagnostics in resource-limited settings have left a long trail of suggested …

Iron deficiency as a public health problem is based on the seriousness of its consequences
on human health suggesting that certain indices of iron status are associated with …

Background: Standard methods of CD4 counts and plasma viral load estimation require
specialized equipment, highly trained personnel and are extremely expensive. This remains …